BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr | ₹24 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr | ₹24 Cr |
Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr | ₹24 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | ₹55 Cr | - |
Total Reserves | ₹50 Cr | ₹38 Cr | ₹33 Cr | ₹-6.78 Cr | ₹-2.86 Cr |
Securities Premium | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹41 Cr | ₹41 Cr |
Capital Reserves | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹5.69 Cr |
Profit & Loss Account Balance | ₹-54 Cr | ₹-66 Cr | ₹-71 Cr | ₹-77 Cr | ₹-52 Cr |
General Reserves | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹50 Cr | ₹38 Cr | ₹33 Cr | ₹-6.78 Cr | ₹-2.86 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹73 Cr | ₹62 Cr | ₹57 Cr | ₹51 Cr | ₹21 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹6.93 Cr | ₹3.30 Cr | ₹2.50 Cr | - | ₹21 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹9.51 Cr | ₹4.45 Cr | - | - | ₹19 Cr |
Term Loans - Institutions | - | - | ₹2.50 Cr | - | - |
Other Secured | ₹-2.58 Cr | ₹-1.15 Cr | - | - | ₹2.04 Cr |
Unsecured Loans | ₹1.51 Cr | ₹2.02 Cr | - | ₹3.02 Cr | ₹2.13 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹1.51 Cr | ₹2.02 Cr | - | ₹3.02 Cr | ₹2.13 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | - | - | - | - | ₹6.18 Cr |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | - | - | - | - | ₹6.18 Cr |
Other Long Term Liabilities | ₹1.22 Cr | ₹0.85 Cr | ₹2.79 Cr | - | ₹0.03 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | ₹0.10 Cr | - | - |
Total Non-Current Liabilities | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr | ₹3.02 Cr | ₹29 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹28 Cr | ₹12 Cr | ₹11 Cr | ₹13 Cr | ₹39 Cr |
Sundry Creditors | ₹28 Cr | ₹12 Cr | ₹11 Cr | ₹13 Cr | ₹39 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹5.48 Cr | ₹3.46 Cr | ₹3.62 Cr | ₹4.56 Cr | ₹7.99 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.04 Cr | - | ₹0.89 Cr | ₹2.51 Cr | ₹1.25 Cr |
Interest Accrued But Not Due | ₹0.11 Cr | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹5.33 Cr | ₹3.46 Cr | ₹2.73 Cr | ₹2.05 Cr | ₹6.73 Cr |
Short Term Borrowings | ₹12 Cr | ₹4.59 Cr | ₹10.00 Cr | - | ₹23 Cr |
Secured ST Loans repayable on Demands | ₹12 Cr | ₹4.59 Cr | - | - | ₹23 Cr |
Working Capital Loans- Sec | ₹12 Cr | ₹4.59 Cr | - | - | ₹23 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-12 Cr | ₹-4.59 Cr | ₹10.00 Cr | - | ₹-23 Cr |
Short Term Provisions | ₹0.63 Cr | ₹1.56 Cr | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.63 Cr | ₹1.56 Cr | - | - | - |
Total Current Liabilities | ₹46 Cr | ₹22 Cr | ₹24 Cr | ₹17 Cr | ₹71 Cr |
Total Liabilities | ₹130 Cr | ₹90 Cr | ₹86 Cr | ₹71 Cr | ₹121 Cr |
ASSETS | |||||
Gross Block | ₹95 Cr | ₹88 Cr | ₹80 Cr | ₹74 Cr | ₹73 Cr |
Less: Accumulated Depreciation | ₹54 Cr | ₹49 Cr | ₹44 Cr | ₹39 Cr | ₹36 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹40 Cr | ₹39 Cr | ₹36 Cr | ₹35 Cr | ₹37 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | ₹0.83 Cr | ₹0.21 Cr | - |
Non Current Investments | - | - | - | - | ₹1.43 Cr |
Long Term Investment | - | - | - | - | ₹1.43 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | ₹1.43 Cr |
Long Term Loans & Advances | ₹0.54 Cr | ₹0.42 Cr | - | - | ₹33 Cr |
Other Non Current Assets | - | - | - | - | ₹1.00 Cr |
Total Non-Current Assets | ₹42 Cr | ₹39 Cr | ₹37 Cr | ₹35 Cr | ₹72 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹9.28 Cr |
Raw Materials | ₹13 Cr | ₹9.77 Cr | ₹9.82 Cr | ₹4.43 Cr | ₹2.92 Cr |
Work-in Progress | ₹5.15 Cr | ₹1.19 Cr | ₹0.97 Cr | ₹2.92 Cr | ₹1.29 Cr |
Finished Goods | ₹2.20 Cr | ₹3.24 Cr | ₹1.68 Cr | ₹2.69 Cr | ₹1.08 Cr |
Packing Materials | - | - | ₹2.73 Cr | ₹1.20 Cr | ₹0.89 Cr |
Stores Ā and Spare | ₹1.96 Cr | ₹6.08 Cr | ₹0.24 Cr | ₹0.18 Cr | ₹3.11 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹41 Cr | ₹15 Cr | ₹9.56 Cr | ₹6.04 Cr | ₹25 Cr |
Debtors more than Six months | ₹4.72 Cr | ₹2.08 Cr | - | ₹0.75 Cr | ₹6.34 Cr |
Debtors Others | ₹37 Cr | ₹13 Cr | ₹9.56 Cr | ₹5.28 Cr | ₹18 Cr |
Cash and Bank | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr | ₹2.70 Cr |
Cash in hand | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Balances at Bank | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr | ₹2.70 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.37 Cr | ₹0.28 Cr | ₹12 Cr | ₹7.42 Cr | ₹6.24 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | ₹0.35 Cr | ₹0.31 Cr | ₹0.28 Cr |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.37 Cr | ₹0.28 Cr | ₹0.23 Cr | ₹0.13 Cr | ₹0.08 Cr |
Other current_assets | - | - | ₹11 Cr | ₹6.98 Cr | ₹5.88 Cr |
Short Term Loans and Advances | ₹16 Cr | ₹15 Cr | ₹11 Cr | ₹2.54 Cr | ₹5.19 Cr |
Advances recoverable in cash or in kind | ₹1.02 Cr | ₹0.64 Cr | ₹11 Cr | ₹2.03 Cr | - |
Advance income tax and TDS | ₹0.48 Cr | ₹0.63 Cr | ₹0.56 Cr | ₹0.43 Cr | ₹0.34 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹14 Cr | ₹14 Cr | ₹0.16 Cr | ₹0.07 Cr | ₹4.85 Cr |
Total Current Assets | ₹87 Cr | ₹51 Cr | ₹50 Cr | ₹36 Cr | ₹48 Cr |
Net Current Assets (Including Current Investments) | ₹41 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹-22 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹130 Cr | ₹90 Cr | ₹86 Cr | ₹71 Cr | ₹121 Cr |
Contingent Liabilities | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | ₹5.00 Cr | ₹0.03 Cr |
Total Debt | ₹23 Cr | ₹11 Cr | ₹13 Cr | ₹3.02 Cr | ₹46 Cr |
Book Value | 31.05 | 26.19 | 24.00 | -18.64 | 8.79 |
Adjusted Book Value | 31.05 | 26.19 | 24.00 | -18.64 | 8.79 |
Compare Balance Sheet of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹200.9 Cr | -1% | -11.8% | -18% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹369,402.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹109,341.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,341.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹99,176.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,543.1 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -1% |
-11.8% |
-18% |
SENSEX | -0.8% |
1.4% |
22.9% |
You may also like the below Video Courses